Inhibition and escape of SARS-CoV treated with antisense morpholino oligomers

Advances in Experimental Medicine and Biology

Volumn 581, Issue , 2006, Pages 567-571

  Neuman, Benjamin W ^a   Stein, David A ^b   Kroeker, Andrew D ^b   Bestwick, Richard K ^b   Iversen, Patrick L ^b   Moulton, Hong M ^b   Buchmeier, Michael J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b AVI BIOPHARMA INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84934443008     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-33012-9_103     Document Type: Conference Paper

References (17)

1. U. Bacha, J. Barrila, A. Velazquez-Campoy, S. A. Leavitt, and E. Freire, Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro, Biochemistry 43, 4906-4912 (2004).
2. R. Y. Kao, W. H. Tsui, T. S. Lee, et al., Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics, Chem. Biol. 11, 1293-1299 (2004).
3. C. Y. Wu, J. T. Jan, S. H. Ma, et al., Small molecules targeting severe acute respiratory syndrome human coronavirus, Proc. Natl. Acad. Sci. USA 101, 10012-10017 (2004).
4. M. R. Denison, B. Yount, S. M. Brockway, R. L. Graham, A. C. Sims, X. Lu, and R. S. Baric, Cleavage between replicase proteins p28 and p65 of mouse hepatitis virus is not required for virus replication, J. Virol. 78, 5957-5965 (2004).
5. E. J. Snijder, P. J. Bredenbeek, J. C. Dobbe,et al., Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage, J. Mol. Biol. 331, 991-1004 (2003).
6. L. Yi, Z. Li, K. Yuan, et al., Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells, J. Virol. 78, 11334-11339. (2004).
7. B. J. Bosch, B. E. Martina, R. Van Der Zee, et al., Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides, Proc. Natl. Acad. Sci. USA 101, 8455-8460 (2004).
8. P. Ingallinella, E. Bianchi, M. Finotto, et al., Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus, Proc. Natl. Acad. Sci. USA 101, 8709-8714 (2004).
9. S. Liu, G. Xiao, Y. Chen, et al., Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors, Lancet 363, 938-947 (2004).
10. K. Yuan, L. Yi, J. Chen, et al., Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein, Biochem. Biophys. Res. Commun. 319, 746-752 (2004).
11. Z. Wang, L. Ren, X. Zhao, T. Hung, A. Meng, J. Wang, and Y. G. Chen, Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells, J. Virol. 78, 7523-7527 (2004).
12. J. Summerton, Morpholino antisense oligomers: the case for an RNase H-independent structural type, Biochim. Biophys. Acta 1489, 141-158 (1999).
13. A. Nasevicius and S. C. Ekker, Effective targeted gene 'knockdown' in zebrafish, Nat. Genet. 26, 216-220 (2000).
14. R. V. Giles, D. G. Spiller, R. E. Clark, and D. M. Tidd, Antisense morpholino oligonucleotide analog induces missplicing of C-myc mRNA, Antisense Nucleic Acid Drug Dev. 9, 213-220 (1999).
15. B. W. Neuman, D. A. Stein, A. D. Kroeker, et al., Antisense morpholino-oligomers directed against the 5′ end of the genome inhibit coronavirus proliferation and growth, J. Virol. 78, 5891-5899 (2004).
16. D. Stein, E. Foster, S. B. Huang, D. Weller, and J. Summerton, A specificity comparison of four antisense types: morpholino, 2′-O-methyl RNA, DNA, and phosphorothioate DNA, Antisense Nucleic Acid Drug Dev. 7, 151-157 (1997).
17. E. M. Westerhout, M. Ooms, M. Vink, A. T. Das, and B. Berkhout, HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome, Nucleic Acids Res. 33, 796-804 (2005).